|
Video: What is a Stock Split?
|
|
IMV, through its subsidiary, ImmunoVaccine Technologies Inc., is a clinical stage biopharmaceutical company that develops products based on its proprietary vaccine enhancement platform with a primary focus on T cell activating therapies for cancers. Co. also capitalizes on licensing opportunities of its platform for other applications including infectious diseases. Co.'s proprietary DepoVax adjuvanting/delivery platform is believed to produce an immune response that has a specific and sustained immune effect, and enables Co. to pursue vaccine candidates in cancer, infectious diseases and potentially other vaccine applications. According to our IMV split history records, IMV has had 1 split. | |
|
IMV (IMV) has 1 split in our IMV split history database. The split for IMV took place on December 13, 2022. This was a 1 for 10 reverse split, meaning for each 10 shares of IMV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as IMV conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the IMV split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into IMV shares, starting with a $10,000 purchase of IMV, presented on a split-history-adjusted basis factoring in the complete IMV split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/04/2014 |
|
End date: |
05/10/2023 |
|
Start price/share: |
$6.20 |
|
End price/share: |
$0.82 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-86.77% |
|
Average Annual Total Return: |
-21.15% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,322.09 |
|
Years: |
8.52 |
|
|
|
Date |
Ratio |
12/13/2022 | 1 for 10 |
|
|